CTRI/2018/04/013202已完成1 期
An open label, balanced, analyst blind, randomized, two treatment, two period, two sequence, single dose, crossover, bioequivalence study of Fenspiride hydrochloride extended release tablets 80 mg of Zuventus Healthcare Ltd. (A JV Company of Emcure Pharmaceuticals Ltd.) with Pneumorel® 80mg (Fenspiride hydrochloride tablets 80 mg) of Servier, France in normal, healthy, adult, human subjects under fasting condition.
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Ba/be
入排标准
入选标准
- •1.Healthy human subjects within 18 - 45 years of age (both inclusive).
- •2.Non-pregnant, non-lactating (for females)
- •3.Body Mass Index of >= 18.5 kg/m2 and <= 24.9 kg/m2.
- •4.Absence of significant disease or clinically significant abnormal laboratory values or laboratory evaluation, medical history or clinical examination.
- •5.Have a normal 12-lead ECG or one with abnormality considered to be clinically insignificant.
- •6.Have a normal chest X-ray PA view (if done)
- •7.Willingness to provide written informed consent to participate in the study, ability to comprehend the nature and purpose of the study.
- •8.Willingness to comply with the requirement of the protocol including all the restrictions.
- •9.Availability of subject for the entire study period.
排除标准
- •1.History of allergy or hypersensitivity to Investigational Product or to its excipients.
- •2.Clinically significant systemic or local disease.
- •3.History of epilepsy or psychiatric disorder.
- •4.Any illness within 21 days or hospitalized or a major illness within the 3 months prior to commencement of the study.
- •5.Any other clinical condition, which may affect the absorption, distribution, biotransformation or excretion of the study drug.
- •6.Presence of any of disease markers of HIV â?? 1 and 2, hepatitis B, C virus.
- •7.Use of any prescribed medication (including herbal or vitamin supplements) during last two weeks or OTC medical products during the last one week preceding the commencement of the study.
- •8.Participated in any other clinical investigation requiring repeated blood sampling / a blood donation program / have blood loss of more than 350 mL in the past 90 days
- •9.History of consumption of alcohol for more than two years & drink more than two alcoholic drinks per day or consumed alcohol within 48 hours prior to commencement of the study or difficulty in abstaining alcohol for the duration of the study. [one drink is equal to one unit of alcohol (one glass wine, half pint beer and one measure i.e. one fluid ounce of spirit)]
- •10.Smoke more than 10 cigarettes / day or Unable to abstain from smoking during the study.
- •11.Consumption of products containing xanthine & nicotine within 48 hours prior to commencement of the study.
- •12.Intake of grapefruits or products containing grapefruits within 72 hours prior to commencement of the study.
- •13.Any significant diet change (eg. low sodium diet) within four weeks prior commencement of the study.
- •14.Use of any recreational drug or a history of drug addiction.
- •15.History of difficulty in accessibility of veins in arms.
- •16.Female subjects not confirming to using birth control measures, from the date of screening until the completion of the last period of the study. [Abstinence, barrier methods (condom, diaphragm, etc.) are acceptable].
- •17.Use of hormonal contraceptives either oral or implants
研究者
相似试验
招募中
Unknown
Clinical study of the test product in healthy human subjectsCTRI/2023/12/060417Dabur India Limited
已完成
3 期
A bridging clinical trial to evaluate the immunogenicity and safety of Three dose THRABIS vaccine in healthy childreCTRI/2023/03/050302Cadila Pharmaceutical Limited354
招募中
3 期
A clinical trial to study the effects of seven sequences of Pranayama and oral hypoglycemic drugs versus only oral hypoglycemic drugs in type 2 diabetes mellitus.CTRI/2010/091/000188Patanjali Ayurved Ltd.Address: Plot no. D-38, Hardwar industrial area,Hardwar -249 40128
进行中（未招募）
3 期
Comparative study of Recombinant human menopausal gonadotrophin in treatment of infertilityCTRI/2017/11/010317Bharat serums and Vaccines ltd309
进行中（未招募）
不适用
An open-label, blinded-endpoint, randomized, prospective trial investigating the effects of vitamin D administration on plasma renin activity in patients with stable chronic heart failure. - VitD-CHFMedDRA version: 12.0Level: LLTClassification code 10008908Term: Chronic heart failureHeart FailureEUCTR2009-015638-31-NLniversity Medical Center Groningen